Log in or Sign up for Free to view tailored content for your specialty!
Practice Management News
Understand bitcoin as a store of value: A guide for physicians
In the rapidly evolving landscape of investments, it is crucial for physicians to stay informed about alternative asset classes, such as cryptocurrency.
Patients in rural areas more likely to die early from preventable deaths
Those who live in rural areas face a higher risk for dying early from preventable deaths, but primary care providers can implement strategies to reduce these disparities, experts said during a CDC press conference.
Log in or Sign up for Free to view tailored content for your specialty!
Icahn School of Medicine names new dean of translational research, therapeutic innovation
Miriam Merad, MD, PhD, has been appointed the new dean of translational research and therapeutic innovation at Mount Sinai’s Icahn School of Medicine.
Study to assess remote screening for financial hardship in patients with cancer
The Patient-Centered Outcomes Research Institute awarded almost $10.5 million to Alliance NCTN Foundation to assess the value of remote digital screening for financial hardship to improve patient-centered outcomes in patients with cancer.
Federal Trade Commission bans most noncompete agreements
In a 3-2 vote, the Federal Trade Commission passed a final rule that bans new noncompete agreements with all workers in for-profit organizations.
Patients of women physicians experience lower mortality, readmission rates
Both male and female patients experienced lower mortality and readmission rates when treated by female physicians, according to study results published in Annals of Internal Medicine.
When should physicians start thinking about medical cannabis for patients?
BOSTON — There is some evidence that cannabinoids may help with neuropathic pain, chemotherapy-induced nausea/vomiting and MS-associated spasticity, “but it’s not exactly a slam dunk,” a speaker said.
Notes from the field: irAE consortium ‘organizing’ providers across specialties
Indications for the use of checkpoint inhibitors are ever expanding. However, even as these drugs have helped patients with cancer live longer, the emergence of various immune related adverse events limits their full potential in many.
Checkpoint inhibitor-related toxicities and patient advocacy: Who will stand up?
I recently had the pleasure of attending a symposium at the Cleveland Clinic that featured an outstanding review of immune-related adverse events, and I was reminded of how far we have come in the decade since I first became involved in the evolution of this disease class.
‘We cannot pour from an empty cup:’ Work-life balance takes priority for today’s providers
When it comes to work-life balance, providers in the past skewed more toward work than life.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read